Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GS homeobox 2 (GSX2) is a DNA-binding transcription factor belonging to the homeobox protein family. It regulates gene expression critical for brain development, particularly during embryogenesis. GSX2 is essential for the specification and differentiation of neuronal progenitors in the telencephalon, including the generation of striatal neurons and olfactory bulb interneurons. Dysregulation or mutation of GSX2 is associated with neurodevelopmental disorders such as diencephalic-mesencephalic junction dysplasia syndrome 2. GSX2 acts by binding specific DNA sequences to control downstream gene expression involved in neural development and differentiation, but it is not currently a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GS homeobox 2 (GSX2).